Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies
- PMID: 10963288
- DOI: 10.1016/S0149-2918(00)80038-7
Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies
Abstract
Background: The effectiveness of specific immunotherapy (SIT) in the treatment of allergic rhinitis has been supported by empirical evidence and clinical experience.
Objective: This report is an analysis of multiple studies involving patients with documented allergic rhinitis.
Methods: All studies of the effectiveness of SIT in the treatment of allergic rhinitis published in English between the years 1966 and 1996 were identified through a MEDLINE search. All prospective, single- or double-blind, placebo-controlled studies were included in the analysis. One author (R.N.R.) extracted data from the studies. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random-effects model for a variety of clinical measures in studies that permitted the extraction of numbers of patients with positive and negative outcomes.
Results: Data were extracted from 16 studies of the clinical effectiveness of SIT in the treatment of allergic rhinitis, involving 759 patients (546 adults, 53 children, 160 all ages). In 15 (94%) of the studies, investigators concluded that SIT was effective. In the remaining study (the only one conducted in children), investigators concluded that SIT was not effective. Symptoms of allergic rhinitis were more likely to improve in patients receiving SIT than in the comparison patients (OR 1.81, 95% CI 1.48 to 2.23). Symptom-medication scores were significantly lower in patients receiving SIT than in the comparison patients in all studies using such measures (P < 0.05).
Conclusion: Results of this analysis support the conclusion that SIT is effective in the treatment of allergic rhinitis.
Similar articles
-
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.Allergy. 2011 Jun;66(6):765-74. doi: 10.1111/j.1398-9995.2011.02590.x. Epub 2011 Apr 18. Allergy. 2011. PMID: 21496059 Review.
-
Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.Allergy. 2008 Dec;63(12):1624-9. doi: 10.1111/j.1398-9995.2008.01743.x. Allergy. 2008. PMID: 19032235
-
Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x. Pediatr Allergy Immunol. 2004. PMID: 15125698 Review.
-
Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: a meta-analysis.Clin Ther. 2000 Mar;22(3):351-8. doi: 10.1016/S0149-2918(00)80039-9. Clin Ther. 2000. PMID: 10963289
-
Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies.Clin Ther. 2000 Mar;22(3):329-41. doi: 10.1016/S0149-2918(00)80037-5. Clin Ther. 2000. PMID: 10963287
Cited by
-
Management of comorbidities in difficult and severe asthma.Breathe (Sheff). 2023 Sep;19(3):230133. doi: 10.1183/20734735.0133-2023. Epub 2023 Nov 14. Breathe (Sheff). 2023. PMID: 38020342 Free PMC article. Review.
-
Dominant Aero-Allergens Involved in Causing Allergic Rhinitis with Special Reference to Dust Mite Allergy and Skin Prick Test in Tripura: A Prospective Study.Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):1028-1032. doi: 10.1007/s12070-020-02108-0. Epub 2020 Aug 31. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 36452553 Free PMC article.
-
Visual analysis of allergic rhinitis in children based on web of science and CiteSpace software.Front Pediatr. 2022 Sep 28;10:911293. doi: 10.3389/fped.2022.911293. eCollection 2022. Front Pediatr. 2022. PMID: 36245734 Free PMC article. Review.
-
Illustrative Case Series and Narrative Review of Therapeutic Failure of Immunotherapy for Allergic Rhinitis.Allergy Rhinol (Providence). 2020 Aug 28;11:2152656720943822. doi: 10.1177/2152656720943822. eCollection 2020 Jan-Dec. Allergy Rhinol (Providence). 2020. PMID: 32923025 Free PMC article. Review.
-
Subcutaneous specific immunotherapy: Economic implications from the perspective of statutory health insurance - a population based cost-effectiveness estimation.Allergol Select. 2018 Sep 1;2(1):111-120. doi: 10.5414/ALX1507E. eCollection 2018. Allergol Select. 2018. PMID: 31826032 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical